-+ 0.00%
-+ 0.00%
-+ 0.00%

Fleury Signs Deal for Atlântica to Take 49.99% Stake in Oncology Venture

PUBT·11/10/2026 21:27:14
Listen to the news
Fleury Signs Deal for Atlântica to Take 49.99% Stake in Oncology Venture
  • Fleury signed a binding memorandum on November 10, 2026, for related party Atlântica to invest in its outpatient oncology business, FleuryOnco.
  • Planned investment totals R$ 72 million through 2027, with FleuryOnco ownership split 50.01% for its parent and 49.99% for Atlântica.
  • The business will comprise seven oncology clinics in São Paulo and Rio de Janeiro, opening between 2026 and 2027.
  • Atlântica is affiliated with Bradesco Diagnóstico, which holds 24.85% of the parent company's common shares.
  • Closing remains subject to CADE approval and definitive agreements.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fleury SA published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.